Scientists at the Feinstein Institute for Medical Research’s department of bioelectric medicine collaborated with colleagues at GE Research to study the use of focused ultrasound to regulate the body’s metabolic and inflammatory systems. Recently published in Nature Communications, the study stimulated nerves at target locations within the liver and spleen to (1) alter metabolic pathways and (2) reduce measurable inflammation markers. This form of peripheral nervous system neuromodulation has immense potential, especially for the mechanisms tested: modulating an anti-inflammatory pathway in the spleen and altering blood glucose levels by targeting glucose sensory neurons in the liver.
See “Noninvasive Sub-organ Ultrasound Stimulation for Targeted Neuromodulation” >